Predictions
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.48
11.09.17
11.09.17
€64.94
15.02.18
15.02.18
9.10%
15.02.18
15.02.18
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€453.60
01.09.17
01.09.17
€526.00
04.11.21
04.11.21
-3.53%
19.11.20
19.11.20
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€68.59
31.08.17
31.08.17
€80.00
10.11.17
10.11.17
3.37%
10.11.17
10.11.17
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Johnson & Johnson
Start price
Target price
Perf. (%)
€116.04
18.07.17
18.07.17
€130.00
08.12.17
08.12.17
4.39%
08.12.17
08.12.17
Johnson & Johnson
Start price
Target price
Perf. (%)
€113.94
19.04.17
19.04.17
€125.00
26.06.17
26.06.17
7.94%
26.06.17
26.06.17
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€30.26
13.02.17
13.02.17
€36.09
13.04.17
13.04.17
-3.46%
13.04.17
13.04.17
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.92
10.11.16
10.11.16
€108.24
10.05.17
10.05.17
-4.12%
10.05.17
10.05.17
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€71.74
10.11.16
10.11.16
€85.00
18.04.17
18.04.17
8.26%
18.04.17
18.04.17
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
7.43%
06.06.24
06.06.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€40.86
08.09.16
08.09.16
€46.00
02.02.17
02.02.17
-22.26%
02.02.17
02.02.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.39
30.08.16
30.08.16
€50.00
02.02.17
02.02.17
-25.03%
02.02.17
02.02.17
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€72.50
05.08.16
05.08.16
€85.69
03.01.18
03.01.18
-3.74%
03.01.18
03.01.18
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€80.73
29.04.16
29.04.16
€100.00
28.03.17
28.03.17
-20.63%
28.03.17
28.03.17
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand